Search

everythinglearnresearchcommunity

for

Search:↓

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

Ketoconazole cured about 70% of cutaneous leishmaniasis cases caused by Leishmania major.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

High-dose vitamin A was safe and well-tolerated in a lung cancer treatment study.

Topical minoxidil is a safe and effective treatment for hair loss caused by androgenetic alopecia.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

Syphilis has a wide range of symptoms that can look like other diseases, and if not treated, it can progress to a more serious stage, especially in HIV-positive patients.

Early diagnosis and treatment of TPP can prevent complications.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Both vertical and transverse sections are useful for diagnosing alopecia, but using both methods together is best.

Treat scalp and beard fungal infections early with oral antifungal medication and sometimes topical therapy, avoiding unnecessary allergy tests and surgery.

COVID-19 infection may trigger alopecia areata in some patients.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

Skin organoids are a promising new model for studying human skin development and testing treatments.

Adipose-derived stem cells (fat cells) show promise in treating hair loss in both men and women.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

The document concludes that while lab results for hair growth promotion are promising, human trials are needed and better testing methods should be developed.

The document concludes that using specific tools and tests is essential for identifying the cause of hair loss and deciding on the right treatment.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Mathematical modeling can improve regenerative medicine by predicting biological processes and optimizing therapy development.

Phototrichogram and hair diameter measurements are effective, noninvasive ways to assess hair growth and detect early hair loss, with the most common pattern being reduced hair density.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

A woman's eyelashes grew thicker and longer after taking topiramate, but returned to normal when she stopped the medication.

The report suggests a possible link between hair loss and hidden scalp tumors but states more evidence is needed to confirm this.

The Brazilian Society of Dermatology agrees that oral isotretinoin is effective for acne and other skin conditions, and it's safe when monitored, but more research is needed on dosing and duration.

A 78-year-old farmer with lung disease had skin lesions from a fungal infection that healed completely with medication.

The document concludes that correct diagnosis of alopecia types is crucial, scalp biopsies are important, and more research is needed.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.